在患有高血压的患者中,左心室缩回归的年龄相关影响
Hyun-Wook Chu1, In-Chang Hwang2,3, Hyue Mee Kim4
1Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, South Korea.
概括
左心室缩 (LVH) 回归在患有高血压的年轻患者中更为常见. 然而,LVH回归对年轻人和老年人的心血管结果都有好处.
科学领域:
- 心脏病学 心脏病学
- 高血压研究 高血压研究
- 老年医学 老年医学
背景情况:
- 左心室缩 (LVH) 是高血压患者心血管事件的关键风险因素.
- 年龄对LVH回归的影响及其预后意义需要进一步澄清.
研究的目的:
- 研究高血压患者的LVH回归的临床影响,考虑到与年龄相关的差异.
- 评估LVH回归的预后价值与不同年龄组的心血管结果相关.
主要方法:
- 分析了1847名高血压患者在基线和治疗期间的回声心脏图数据.
- 由左心室质量指数 (LVMI) 值定义的LVH,适用于男性和女性.
- 年轻人 (<65岁) 和老年人 (≥65岁) 组之间的LVH回归率和血压-LVMI关系的比较.
主要成果:
- 在不同年龄组中,LVH的患病率相似,但在年轻患者中回归更频繁 (36.4%对27.5%).
- 在年轻患者中,缩性血压降低与LVMI降低相关,但在老年人中并非如此.
- 不论年龄,LVH回归与心血管死亡和心力衰竭住院的风险降低有关.
结论:
- 血压降低和LVH回归之间的关联在65岁以下的患者中更为强烈.
- 在年轻和老年高血压患者中,LVH回归显示出对心血管结果的预后价值.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341


